ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $235,967 | +8.6% | 73,510 | +7.3% | 0.04% | -2.2% |
| Q3 2023 | $217,205 | -24.7% | 68,519 | +18.0% | 0.05% | -20.7% |
| Q2 2023 | $288,489 | +10.7% | 58,046 | +10.0% | 0.06% | -22.7% |
| Q1 2023 | $260,625 | -0.9% | 52,758 | +26.2% | 0.08% | -70.6% |
| Q4 2022 | $262,928 | -60.3% | 41,801 | -31.8% | 0.26% | -58.1% |
| Q3 2022 | $662,000 | -35.5% | 61,294 | -31.9% | 0.61% | -22.2% |
| Q2 2022 | $1,026,000 | +21.4% | 89,992 | -3.0% | 0.78% | +96.2% |
| Q1 2022 | $845,000 | -52.6% | 92,755 | -22.4% | 0.40% | -38.7% |
| Q4 2021 | $1,784,000 | – | 119,547 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $46,213,000 | 13.24% |
| Wildcat Capital Management, LLC | 1,716,370 | $44,111,000 | 5.71% |
| TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $481,009,000 | 4.77% |
| Copernicus Capital Management, LLC | 15,000 | $386,000 | 4.67% |
| Coastal Bridge Advisors, LLC | 301,240 | $7,742,000 | 1.79% |
| Lombard Odier Asset Management (Switzerland) SA | 914,416 | $23,500,000 | 1.46% |
| Casdin Capital, LLC | 2,100,000 | $53,970,000 | 1.34% |
| Pier Capital, LLC | 450,182 | $11,570,000 | 1.20% |
| Ghost Tree Capital, LLC | 150,000 | $3,855,000 | 1.13% |
| Sessa Capital IM, L.P. | 750,000 | $19,275,000 | 0.95% |